Getting an insight in the determinants of new product introductions of US biopharmaceutical start-ups
by Bart Clarysse, Koen Debackere
International Journal of Biotechnology (IJBT), Vol. 3, No. 1/2, 2001

Abstract: This paper analyses which organisational and industrial factors influence the chance that a US biopharmaceutical start-up is able to introduce a new drug on the US market. Specific attention is paid to the critical mass a biotech company should obtain to improve its chances of bringing a new drug to the market. In the same vein, the economies of scale in R&D are taken into consideration. Second, we analyse whether a biotech start-up can obtain this optimal scale through merger, internal growth financed by the minority participations of larger partners or through strategic alliances with a pharmaceutical partner. But which of these is the most successful with respect to introducing a new drug on the market. To analyse these questions, data on their NDA and R&D activities is collected for all US biotech companies, involved in biopharmaceutical research and development, with more than 50 employees over the period 1982-1994. The findings are challenging, at least. Although many biotech companies are well below the minimum critical mass necessary to introduce a new drug on the market, internal growth through minority participations seems to be a very unsuccessful strategy. The real trade-off seems to be between merger and strategic partnering.

Online publication date: Sun, 13-Jul-2003

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com